Symbiotec IPO draws positive brokerage views on strong API portfolio growth ...Middle East

Business Standard - Economy
Symbiotec IPO draws positive brokerage views on strong API portfolio growth
Symbiotec Pharmalab IPO is a mix of a fresh issue of ₹15 lakh and an offer for sale of ₹1.63 crore. The price band for the offer is set issue price band at ₹938 to ₹988 per share.

Hence then, the article about symbiotec ipo draws positive brokerage views on strong api portfolio growth was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Symbiotec IPO draws positive brokerage views on strong API portfolio growth )

Apple Storegoogle play

Last updated :

Also on site :